Asarfi Hospital Ltd (ASARFI) — shareholding pattern, promoter holding, financials and share price
About Asarfi Hospital Ltd (ASARFI)
Asarfi Hospital Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as ASARFI and on the BSE under scrip code 543943. Its ISIN is INE0DN001027.
Incorporated in 2005, Asarfi Hospital Ltd provides primary health services & treatment and specialized super speciality health service [1]
Asarfi Hospital Limited is an integrated healthcare services provider based in Dhanbad, Jharkhand, operating two hospitals with a combined capacity of 330 beds across a Super‑Specialty hospital and a dedicated Cancer Institute, delivering tertiary care across cardiology, neurosciences, oncology and multiple specialties to eastern India’s regional population.
The company reported strong recent operating momentum with standalone Q3 FY26 revenue of ₹46.06 crore (40% YoY growth), EBITDA margins of 22% and PAT margins of 12%, reflecting a three‑year revenue CAGR of 23% and operating leverage as oncology and specialty volumes scale.
Listed peers in Hospital: KRM Ayurveda Ltd, Hannah Joseph Hospital Ltd, Lotus Eye Hospital & Institute Ltd, Aashka Hospitals Ltd, Abate As Industries Ltd, Fortis Malar Hospitals Ltd.
Valuation & Returns
10 Jul 2026At ₹216.45 a share on 10 Jul 2026, Asarfi Hospital Ltd (ASARFI) was valued at a price-to-earnings ratio of 25.57x against an industry P/E of 61.73x and a price-to-book of 5.26x on a book value of ₹41.16 per share as of Mar 2025. Solomo computes return on equity of 20.57% and return on capital employed of 20.42% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 25.57x
- Industry P/E
- 61.73x
- P/B
- 5.26x
- EPS (TTM)
- ₹8.47
- Book value / share
- ₹41.16
- ROE
- 20.57%
- ROCE
- 20.42%
- ROA
- 10.17%
- Debt / equity
- 0.6x
- Dividend yield
- 0%
- EBITDA margin
- 21.99%
- 52-week range
- ₹117.2 – ₹256.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Asarfi Hospital Ltd (ASARFI) reported revenue of ₹174 crore, net profit of ₹17 crore and earnings per share of ₹8.47. That compares with revenue of ₹116 crore and net profit of ₹11 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹45.24 crore and net profit ₹3.92 crore (consolidated).
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue (₹ cr) | 81 | 116 | 174 |
| Net profit (₹ cr) | 4 | 11 | 17 |
| EPS (₹) | 2.11 | 5.38 | 8.47 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 22.98% | 22.73% | 42.86% |
| Profit growth | 33.11% | 24.22% | 154.33% |
| Stock price CAGR | - | - | 58% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 61.17% of Asarfi Hospital Ltd (ASARFI) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 2.97%. Market capitalisation was ₹426 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.
Largest disclosed public shareholders in Jun 2026: GOPAL SINGH 2.4%, SUKANTI KUMAR DAS 1.68%, HUF 1.13%, SAROJ SINGH 1.03%, INDU JAIN 1.02%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 61.17% | - | - | 2.97% | 38.83% |
| Mar 2026 | 61.17% | - | - | 2.4% | 38.83% |
| Dec 2025 | 61.17% | - | - | 1.98% | 38.83% |
| Sep 2025 | 61.17% | - | 0.05% | 2.19% | 38.83% |
| Jun 2025 | 61.17% | - | 0.1% | 3.18% | 38.83% |
| Mar 2025 | 61.17% | - | - | 2.92% | 38.83% |
| Sep 2024 | 61.17% | - | - | 1.95% | 38.83% |
| Mar 2024 | 61.17% | - | - | 2.33% | 38.83% |